News | February 14, 2022
Divi’s Labs Q3 driven by custom synthesis; margins sustainable: ICICI Direct
Key takeaways of recent quarter & conference call highlights
Key takeaways of recent quarter & conference call highlights
Dr. Reddy’s to promote and distribute select Novartis products including the Voveran range, the Calcium range and Methergine in India
On track to complete the BLA submission in the first half of 2022
MedleyMed is present across the pharma and healthcare value chain. It offers digital solutions to all stake holders and is in the process of expanding its operations in India and USA. In an interview with Thomas C Thottathil, M Satyendra (Satish), Managing Director, Athena Global Technologies & MedleyMed discussed his plans and opportunities in India
Cysoni is a bionic device that paces the heart with real-time respiratory modulation. The innovation stems from the idea that heart rate increases and decreases with each breath in normal physiology, termed ‘respiratory sinus arrhythmia’ (RSA)
In the first phase of the Grangemouth site expansion, two new ADC manufacturing suites, operational by Q3 2023, will be added to the existing three
Singapore Health Sciences Authority (HSA) approval marks the first in a series of expected approvals of trodelvy in Asia
Under the terms of the agreement, Biogen will make an upfront payment of US $ 8 million to Xbrane
Newly formed Life Science Services business unit to offer fully integrated CDMO and Contract Testing Services
Granules India has reported consolidated financial results for the period ended December 31, 2021
Subscribe To Our Newsletter & Stay Updated
